180 related articles for article (PubMed ID: 33613515)
1. TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9.
Chao M; Liu N; Sun Z; Jiang Y; Jiang T; Xv M; Jia L; Tu Y; Wang L
Front Immunol; 2020; 11():592080. PubMed ID: 33613515
[TBL] [Abstract][Full Text] [Related]
2. TGF beta signaling and its role in glioma pathogenesis.
Kaminska B; Kocyk M; Kijewska M
Adv Exp Med Biol; 2013; 986():171-87. PubMed ID: 22879069
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profile analysis of U251 glioma cells with shRNA-mediated SOX9 knockdown.
Ren D; Yang C; Liu N; Wang Z; Wang X; Johnson M; Wang W; Zhang P; Yang H; Liu H; Cheng Y; Wang L; Tu Y
J BUON; 2018; 23(4):1136-1148. PubMed ID: 30358223
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
Gao J; Zhang JY; Li YH; Ren F
Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic role of SOX9 expression in human malignant glioma.
Wang L; He S; Yuan J; Mao X; Cao Y; Zong J; Tu Y; Zhang Y
Med Oncol; 2012 Dec; 29(5):3484-90. PubMed ID: 22714060
[TBL] [Abstract][Full Text] [Related]
7. SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling.
Liu H; Liu Z; Jiang B; Peng R; Ma Z; Lu J
Cell Biochem Biophys; 2015 Sep; 73(1):205-12. PubMed ID: 25716338
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
9. Curcumin Can Improve Spinal Cord Injury by Inhibiting TGF-β-SOX9 Signaling Pathway.
Yuan J; Botchway BOA; Zhang Y; Tan X; Wang X; Liu X
Cell Mol Neurobiol; 2019 Jul; 39(5):569-575. PubMed ID: 30915623
[TBL] [Abstract][Full Text] [Related]
10. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Understanding Mechanisms of TGF Beta Signaling and Its Role in Glioma Pathogenesis.
Kaminska B; Cyranowski S
Adv Exp Med Biol; 2020; 1202():179-201. PubMed ID: 32034714
[TBL] [Abstract][Full Text] [Related]
13. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
14. Interaction of transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells.
Held-Feindt J; Lütjohann B; Ungefroren H; Mehdorn HM; Mentlein R
J Neurooncol; 2003 Jun; 63(2):117-27. PubMed ID: 12825816
[TBL] [Abstract][Full Text] [Related]
15. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
[TBL] [Abstract][Full Text] [Related]
16. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
17. TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy.
Guo Z; Li G; Bian E; Ma CC; Wan J; Zhao B
Biomed Pharmacother; 2017 Oct; 94():774-780. PubMed ID: 28802229
[TBL] [Abstract][Full Text] [Related]
18. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
Ashley DM; Kong FM; Bigner DD; Hale LP
Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
[TBL] [Abstract][Full Text] [Related]
19. mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.
Garros-Regulez L; Aldaz P; Arrizabalaga O; Moncho-Amor V; Carrasco-Garcia E; Manterola L; Moreno-Cugnon L; Barrena C; Villanua J; Ruiz I; Pollard S; Lovell-Badge R; Sampron N; Garcia I; Matheu A
Expert Opin Ther Targets; 2016; 20(4):393-405. PubMed ID: 26878385
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta and its implication in the malignancy of gliomas.
Roy LO; Poirier MB; Fortin D
Target Oncol; 2015 Mar; 10(1):1-14. PubMed ID: 24590691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
